Ken Blount PhD,
Dr. Blount, Ph.D., CSO Rebiotix Inc, a Ferring Company and VP Microbiome Research Ferring, is a seasoned director of collaborative research programs in biotech, pharma, clinical, and academic research settings, and his scientific expertise includes antibiotics discovery and development, fecal microbiome analysis, translational medical oncology, and RNA-targeting therapeutics.
